We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

112 hedge funds and large institutions have $26M invested in SANGAMO THERAPEUTICS INC in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 16

81% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 16

12.82% more ownership

Funds ownership: 18.5% → 31.32% (+13%)

7% more funds holding

Funds holding: 105 → 112 (+7)

9% more call options, than puts

Call options by funds: $344K | Put options by funds: $315K

0% less capital invested

Capital invested by funds: $26.2M → $26M (-$127K)

Holders
112
Holders Change
+7
Holders Change %
+6.67%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
30
Reduced
16
Closed
16
Calls
$344K
Puts
$315K
Net Calls
+$29K
Net Calls Change
+$48K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$16.1M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$2.1M
3
Bank of America
Bank of America
North Carolina
+$694K
4
UBS Group
UBS Group
Switzerland
+$615K
5
Two Sigma Investments
Two Sigma Investments
New York
+$603K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$1.83M
2
Jane Street
Jane Street
New York
-$1.16M
3
WA
Wasatch Advisors
Utah
-$595K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$179K
5
GCM
Graham Capital Management
Connecticut
-$135K
Name Holding Trade Value Shares
Change 		Change in
Stake
PWMG
101
Prestige Wealth Management Group
New Jersey
$75 – – –
BNP Paribas Financial Markets
102
BNP Paribas Financial Markets
France
$66 – – –
SAM
103
Smartleaf Asset Management
Massachusetts
$61 – – –
AF
104
Advisornet Financial
Minnesota
$51 – – –
National Bank of Canada
105
National Bank of Canada
Quebec, Canada
$49 – – –
ASN
106
Advisory Services Network
Georgia
$49 +$80 +200 New
VNT
107
Vanguard National Trust
Pennsylvania
$33 +$54 +135 New
SWM
108
SHP Wealth Management
Massachusetts
$31 – – –
CA
109
Crewe Advisors
Utah
$25 – – –
MCM
110
MAI Capital Management
Ohio
$25 – – –
US Bancorp
111
US Bancorp
Minnesota
$3 – – –
Two Sigma Advisers
112
Two Sigma Advisers
New York
– -$1.82M -4,343,255 Closed
Jane Street
113
Jane Street
New York
– -$1.16M -2,918,127 Closed
WA
114
Wasatch Advisors
Utah
– -$595K -1,416,717 Closed
GCM
115
Graham Capital Management
Connecticut
– -$135K -321,837 Closed
VF
116
Virtu Financial
New York
– -$56K -132,356 Closed
SOW
117
State of Wyoming
Wyoming
– -$46.8K -111,527 Closed
GCP
118
GSA Capital Partners
United Kingdom
– -$33K -78,148 Closed
Cetera Investment Advisers
119
Cetera Investment Advisers
Illinois
– -$30.8K -73,300 Closed
Mariner
120
Mariner
Kansas
– -$23.8K -56,732 Closed
JFG
121
Jefferies Financial Group
New York
– -$22.5K -53,600 Closed
Millennium Management
122
Millennium Management
New York
– -$15.8K -37,703 Closed
LTAS
123
Linden Thomas Advisory Services
North Carolina
– -$8.25K -19,635 Closed
Jones Financial Companies
124
Jones Financial Companies
Missouri
– -$583 -1,388 Closed
FFO
125
Fortitude Family Office
Arizona
– -$473 -1,126 Closed
2 3 4
5
6

SGMO Hedge Fund Activity: Q1 2026 in Review

112 of the 8,142 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2026, worth a combined $26M — down 0.48% from $26.2M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SGMO positions and 16 closed out — a net gain of 13 holders — while 30 added to existing stakes and 16 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $16.1M. The largest seller was Renaissance Technologies, cutting an estimated $1.83M.

  • 112 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2026, up from 105 in Q4 2025.
  • Funds reported $26M of SANGAMO THERAPEUTICS INC stock for Q1 2026, down 0.48% quarter-over-quarter.
  • 29 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2026 and 16 closed out, a net change of +13 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q1 2026 was Armistice Capital, an estimated $16.1M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q1 2026 was Renaissance Technologies, an estimated $1.83M sold.

Based on aggregated 13F filings for Q1 2026.